A judge in St. Louis, Missouri ordered Johnson & Johnson to pay plaintiff Gloria Ristesund $55 million in damages for allegedly “failing to warn consumers of known risks” associated with their talcum powder – the second verdict of its kind, to date. In February, the same court awarded $72 million to the... Read more »

Fresenius Medical Care North America agreed to a $250 million settlement to resolve lawsuits that claim the company was aware of risks of their dialysis products yet failed to warn the public. The litigation centers upon Granuflo and Naturalyte, two dialysates that have been blamed for heart problems, strokes and death... Read more »

A Missouri jury has awarded $72 million to the family of a woman after determining her ovarian cancer was directly linked to decades of use of talcum powder products manufactured by Johnson & Johnson. The verdict was the first to award damages to a plaintiff after determining the pharmaceutical giant... Read more »

An appeal by Johnson & Johnson to overturn a $124 million verdict against the company has been rejected by the U.S. Supreme Court. The verdict involved the pharmaceutical giant’s drug Risperdal, an atypical antipsychotic the state of South Carolina alleged was illegally marketed by the company. Lawsuit alleges deceptive marketing... Read more »

A settlement has been reached between the Kentucky Attorney General and Johnson & Johnson regarding the schizophrenia drug Risperdal. The lawsuit was originally filed with allegations that the pharmaceutical giant and its subsidiary Janssen Pharmaceuticals hid some of the drug’s side effects from consumers, while marketing it for off-label use... Read more »

A man has been awarded $1.75 million by a jury that determined his breast growth was caused by his use of Risperdal as a child. This is the fourth trial involving the link between Risperdal and male breast growth. The first two also resulted in decisions favoring the plaintiffs and the... Read more »

Bayer Healthcare Pharmaceuticals has reported substantial progress during the latest status conference for the multidistrict litigation (MDL) No. 2100 regarding Yaz and Yasmin lawsuits. The status conference took place early in November 2015. It was presided over by U.S. District Judge David R. Herndon of the Southern District of Illinois.... Read more »

A Philadelphia jury has ordered Janssen Pharmaceuticals — a Johnson & Johnson subsidiary — to pay $1.8 million to a man who developed breasts while taking the pharmaceutical giant’s antipsychotic drug Risperdal. Jurors determined that the company knew the prescription medication could trigger atypical breast growth, but failed to properly... Read more »

According to a recent announcement by Actos manufacturer Takeda Pharmaceuticals, over 96 percent of the eligible claimants have agreed to take part in the Actos product liability resolution program. Through the program, over 9,000 plaintiffs may receive compensation for their injuries without the uncertainty that exists in continued litigation. With over... Read more »

When is paying $2.2 billion ever a bargain? According to University of Michigan professor and class action settlement expert Eric Gordon, Japanese drug giant Takeda’s decision to offer one of the largest drug settlements in US history to settle 8,ooo pending lawsuits against it may be just that. Actos users... Read more »